Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

EuroIntervention 2018;14:e397-e404 published online April 2018 published online e-edition July 2018. DOI: 10.4244/EIJ-D-17-00546

Moritz Seiffert
Moritz Seiffert1, MD; Hendrik Treede2, MD; Joachim Schofer3, MD; Axel Linke4, MD; Jochen Wöhrle5, MD; Hardy Baumbach6, MD; Julinda Mehilli7, MD; Vinayak Bapat8, MD; Matheus Simonato9; Thomas Walther10, MD; Mathias Kullmer11, MD; Peter Boekstegers12, MD; Stephan Ensminger13, MD; Thomas Kurz14, MD; Helene Eltchaninoff15, MD; Ardawan Rastan16, MD; Nicolas Werner17, MD; Arend de Weger18, MD; Christian Frerker19, MD; Bernward Lauer
1. University Heart Center Hamburg, Hamburg, and DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany; 2. University Hospital Halle, Halle (Saale), Germany; 3. Albertinen Heart and Vascular Center, Hamburg,

Aims: Transcatheter valve-in-valve implantation (VinV) is established for the treatment of degenerated surgical bioprostheses in patients at high operative risk. Our aim was to report on

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic regurgitationaortic stenosisdegenerative valvetavivalve-in-valve
Interventions for valvular diseaseTAVI
Read next article
Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model

Latest news